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ABSTRACT 
Rift Valley fever virus (RVFV) is a mosquito-borne arbovirus causing severe disease in 
humans and ruminants. Spread of RVFV out of Africa has raised concerns that it could 
emerge in Europe or the USA. Virus persistence is dependent on successful infection of, 
replication in, and transmission to susceptible vertebrate and invertebrate hosts, modulated 
by virus-host and vector-virus interactions. The principal accepted theory for the long term 
maintenance of RVFV involves vertical transmission (VT) of virus to mosquito progeny, with 
the virus surviving long inter-epizootic periods within the egg. This VT hypothesis however, 
is yet to be comprehensively proven. Here, evidence for and against the VT of RVFV is 
reviewed along with the identification of factors limiting its detection in natural and 
experimental data. The observation of VT for other arboviruses in the genera alphavirus, 
flavivirus and orthobunyavirus are discussed within the context of RVFV. The review 
concludes that VT of RVFV is likely but that current data are insufficient to irrefutably prove 
this hypothesis.   
  
1. INTRODUCTION: 1 
Rift Valley fever virus (RVFV; Bunyaviridae; Phlebovirus), the causative agent of Rift 2 
Valley fever (RVF) is primarily transmitted to humans and livestock by mosquitoes [1,2]. 3 
Mortality rates and clinical signs in ruminants, including: fever, weakness, anorexia, and 4 
abortion [1,3,4], are influenced by age and species. Humans are also infected by aerosol or 5 
percutaneous routes [5,6], causing a febrile illness and in 1% of cases encephalitis or 6 
haemorrhagic fever  [7]. Despite the severity, there is no licensed vaccine to protect humans 7 
but three vaccines are available for animal use in endemic regions [reviewed by, 8].  8 
RVFV has a tri-segmented, negative or ambisense ssRNA genome [9]. The small (S) 9 
segment encodes the nucleoprotein (N) and non-structural protein (NSs), involved in 10 
evading the host immune system [10]. Segments are encapsidated by N, facilitating 11 
replication and transcription in association with the polymerase encoded on the large (L) 12 
segment. The medium (M) segment encodes two non-structural proteins, NSm1 (78kDa) 13 
and NSm2 (14kDa), and two envelope glycoproteins, Gn and Gc [11,12].  14 
RVFV was first isolated in Kenya 1930 [1], with subsequent major outbreaks in: South 15 
Africa 1950-1951 [reviewed by, 13], Egypt 1977-1979 [14], Mauritania 1987 [15], and 16 
Madagascar in 1990, 11 years after its detection in mosquitoes [16–18]. The first outbreak 17 
outside of Africa, in the Arabian Peninsula 2000 [19], resulted in a predicted economic 18 
burden of US$90 million [20]. Therefore potential spread to, and establishment in, non-19 
endemic regions such as Europe and USA, would severely impact the health of humans, 20 
livestock, and the economy, particularly as vaccination is not available in many areas. 21 
Critical stages for pathogen emergence are introduction, establishment, and spread 22 
[21].  Potential routes of entry of RVFV into Europe and the USA have been identified [22–23 
24] and the risk of establishment into North Africa [25], Italy [26], the Netherlands [27], and 24 
  
Spain [28] reviewed. The conclusions collectively identify a need to determine competence 25 
in local vectors to accurately evaluate risks, and guide control and surveillance activities 26 
[23,24]. The presence of competent vectors and hosts are essential but must coincide with 27 
multiple factors such as sufficient livestock density, rainfall providing vector breeding sites, 28 
and temperatures that support vector development and pathogen replication [29]. 29 
Disease pathology and endemic maintenance within mammalian hosts have been 30 
extensively reviewed [30–35] but vector-virus interactions are less well understood. Central 31 
to RVFV survival is the concept that virus is passed vertically to mosquito offspring, surviving 32 
in the eggs during long inter-epizootic periods. However, this vertical transmission (VT) 33 
hypothesis is yet to be comprehensively proven. Here, evidence for and against the VT of 34 
RVFV is discussed within the context of the knowledge of other arboviruses. 35 
2. TRANSMISSION CYCLE 36 
Since the identification of RVFV, mosquitoes have been implicated as the transmission 37 
vector [1,36]. RVFV can infect a broad range of arthropods including Culicoides biting midges 38 
[37], phelbotomine sandflies [38], and ticks [39,40]. However, as supporting data are either 39 
experimental or natural but not both, transmission by arthropods other than mosquitoes is 40 
considered mechanical and not biological. RVFV has been detected in over 50 mosquito 41 
species in endemic regions and competency demonstrated in at least 47 [41,42], 42 
predominantly within the genera Aedes and Culex, Table 1.  43 
Epidemic/ Epizootic cycle 44 
During epizootics RVFV is maintained by horizontal transmission (HT) between 45 
ruminants and mosquitoes, (Fig. 1). Although not resolved, humans are considered dead-46 
end hosts with minimal involvement in viral amplification [4,23]. Infection of mosquitoes is 47 
dose-dependent so, to be considered an amplifying host, titres must be sufficiently high and 48 
  
duration sufficiently long to support onward transmission. Natural viraemias in humans are  49 
1-8 log10PFU/mL (on average detected three days post onset) [14,43], and in livestock 6-8 50 
log10PFU/mL [4,44], lasting up to five days in calves and lambs [45]. Average viral titres in 51 
engorged mosquitoes are 100-fold lower than in the blood meal, Table 1 [46,47]. Using in-52 
vitro saliva collections it is calculated that mosquitoes inject around 50 PFU/mL RVFV with 53 
each bite [48,49] although analysis of West Nile virus (WNV;  Flavivirus), suggest these 54 
methods underestimate titres and vary between species [50]. 55 
Inter-epidemic/-epizootic and Endemic/Enzootic cycle 56 
During periods of adverse conditions for the vector, such as drought [51], the 57 
abundance of mosquitoes is insufficient to support widespread HT, leading to inter-epizootic 58 
periods lasting five to fifteen years [52]. There is evidence that livestock contribute to a low 59 
or sub-clinical level of virus maintenance but detection requires active longitudinal 60 
surveillance [53,54]. Retrospective phylogenetic studies revealing the presence of strains 61 
from multiple lineages in Central Africa offer further support [34]. The role of wild species is 62 
unanswered but low level circulation of RVFV in buffalo is reported in Kenya, Botswana, and 63 
South Africa [55–57], and mortalities in giraffe, waterbuck, and springbok [32,58].  64 
The principal hypothesis in the literature for survival of RVFV between epizootics is 65 
by VT of virus from infected mosquito to progeny via the egg [4,23,35,59]. In this scenario, 66 
floodwater Aedes mosquitoes act as maintenance vectors, ovipositing in low lying 67 
grasslands predisposed to seasonal flooding [60].  Aedine eggs can withstand desiccation, 68 
remaining viable for several years. For example, Californian encephalitis virus (CEV; 69 
Orthobunyavirus), remained viable for 19 months within Ae. melanimon eggs [61]. Once 70 
oviposited, the embryo continues developing to a complete first-instar larvae, remaining 71 
dormant within the egg  [62]. Intense and prolonged rainfall, often observed prior to an 72 
  
epizootic, results in huge numbers hatching [52,63]. In Kenya, isolations of RVFV in 73 
mosquitoes, occurred exclusively during flooding [64]. The infected eggs hatch and 74 
mosquitoes feed on ruminants attracted by the floodwater. Floods persisting for weeks 75 
create a semi-permanent habitat for secondary amplifying vectors (usually Culex spp.), 76 
leading to a shift from enzootic to epizootic cycling [65,66]. These mosquitoes oviposit egg 77 
rafts on the water’s surface,  superseding the Aedes spp., feeding on viraemic hosts in the 78 
area. It is during this stage, disease is usually identified in mammals by which point control 79 
and prevention are challenging. Despite general acknowledgement that RVFV survives in the 80 
eggs, the hypothesis and mechanisms are unresolved. 81 
3. RVFV VECTOR COMPETENCE 82 
To understand factors affecting VT detection, it is beneficial to review the study of 83 
vector competence, defined as; the ability of a vector to transmit a microorganism from one 84 
host to another (Fig. 2). The microorganism, taken up in a blood meal, must cross or infect 85 
the gut epithelium, replicate, migrate to the salivary glands, and be transmitted upon blood 86 
feeding [67,68]. Vectorial capacity depends on environmental and behavioural traits such as 87 
vector density, lifespan, biting rate, flight distance, and host feeding preferences [69].  88 
In a competent host, arboviruses are thought to infect midgut epithelial cells by host 89 
cell mediated endocytosis, observed for some Flaviviruses, Alphaviruses, and 90 
Orthobunyaviruses [Reviewed by, 67]. Virus replicates within these cells, exiting into the 91 
haemocoel, commonly simplified into a single measure of dissemination. RVFV titration in 92 
mosquito bodies and legs is an effective way to measure infection and dissemination [70].  93 
Inability to enter or replicate in the midgut epithelium is termed the midgut infection 94 
barrier. Delay or prevention of  dissemination is collectively termed the midgut escape 95 
barrier and is dose-dependent [71–73]. Multiple mechanisms are postulated for these 96 
  
barriers, specific to each vector-virus pair. These include a physical barrier demonstrated in 97 
Ae. aegypti impacting the dissemination of Plasmodium spp. but not DENV [74], innate 98 
antiviral responses including RNAi [Reviewed by, 75], virus inactivation by digestive 99 
enzymes, and virus incompatibility with host receptors for example deleting NSm in RVFV 100 
impedes infection in Ae. aegypti [67,76,77]. Once in the haemocoel, virus is actively 101 
circulated in the haemolymph to all tissues including the salivary glands and ovaries. Here, 102 
virus must again enter and replicate, remaining until the mosquito feeds or oviposits. A 103 
salivary gland infection barrier has been observed in studies linking transmission to viral 104 
dose [47,72]. The basal lamina is proposed as a physical barrier to the salivary glands 105 
observed by ultrastructural studies of WNV and Venezuelan equine encephalitis virus (VEEV; 106 
Alphavirus), [78]. It is an extracellular matrix surrounding all insect tissues preventing free 107 
movement of macromolecules in and out of the haemolymph, with pore sizes smaller than 108 
an arbovirus. RVFV appears to bud into areas of modified basal lamina but its role in 109 
dissemination to the ovaries is unknown [76,79].  110 
4. VERTICAL TRANSMISSION 111 
Three routes of VT have been postulated: Transovum transmission which is proposed 112 
for flaviviruses [80–82], involves virus entry into a fully formed, chorionated oocyte through 113 
the micropyle during fertilisation by an infected male. This requires prior infection of the 114 
male population which can only be achieved by VT. Transovum transmission can therefore 115 
amplify but not initiate VT. Transovarian transmission (TOT), which requires prior infection 116 
of germ tissues with virus entering oocytes as they develop within the ovaries and is 117 
reportedly more efficient than transovum transmission [81]. Thirdly the contamination of 118 
the oocyte surface with subsequent ingestion of virus by the developing larvae, which was 119 
theorised but then contradicted by experimental data for yellow fever virus (YFV; Flavivirus) 120 
  
and Japanese encephalitis virus (JEV; Flavivirus) [68]. Though transmission of RVFV after 121 
ingestion by larvae has been demonstrated [83], the latter route seems unlikely to give rise 122 
to viral maintenance during inter-epizootic periods which requires the virus to survive for 123 
several years. There are limited data on the stability of virus in dry environments, although 124 
RVFV titres decline within days at ambient temperatures outside of a protein rich 125 
environment [41]. However Romoser et al., postulated that high titres of virus within the 126 
egg could be a source of RVFV for feeding larvae [84].  127 
It is logical to assume that arboviruses adopt both vertical and horizontal strategies 128 
to promote survival under a range of ecological conditions and pressures [85]. The 129 
mathematically predicted rates required for RVFV maintenance by VT alone are deemed 130 
improbable in a natural setting [86]. Consideration of the mosquito-borne arboviruses 131 
within the genera Flavivirus, Alphavirus, Orthobunyavirus, and Phlebovirus has highlighted 132 
the rare occurrence of VT, typically <0.1% [81,87]. The likely involvement of a mammalian 133 
reservoir is well supported although more data on transmission and egg survival rates are 134 
required to improve the accuracy of these calculations [87,88]. 135 
Field data 136 
Observations of VT in natural studies typically involve detection of virus in the eggs, 137 
larvae or adult males. RVFV, detected in adult male and female Ae. mcintoshi (originally 138 
reported as Ae. lineatopennis [89]), reared in the laboratory from field collected eggs, forms 139 
the principal support for VT of RVFV but replicating these findings has proven difficult [64]. 140 
Detection of RVFV RNA in adult male Ae. vexans and Cx. quinquefasciatus collected in Sudan 141 
between 2009 and 2010 by a two-step, end-point RT-PCR offers some support [90]. 142 
However due to the sensitivity and ease of contamination of PCR, results should be 143 
supplemented by a secondary method to detect the presence of infectious virus particles. 144 
  
Circumstantial support for VT is provided by observed RVF outbreaks occurring 145 
simultaneously in distinct regions separated by hundreds of kilometres. Such outbreaks 146 
were observed in provinces of Kenya, Somalia and Tanzania in 2006 [91], and Saudi Arabia, 147 
and Yemen in 2000 [20]. The hypothesis is that as these areas were concurrently exposed to 148 
heavy flooding, the virus was reintroduced into the environment from within the mosquito 149 
eggs, with the eggs providing the initial source for simultaneous epizootics. However, there 150 
is limited phylogenetic, virus isolation or experimental study data to support this 151 
reintroduction of virus. 152 
Laboratory studies 153 
As isolations of RVFV are infrequent in the wild, even when environmental 154 
conditions are favourable (53, 79), infection of mosquitoes in the laboratory is required to 155 
investigate transmission mechanisms. Infection can be performed orally via feeding on a 156 
viraemic animal or artificial blood meal, or intrathoracic inoculation, by injecting virus 157 
through a soft area of cuticle in the thorax directly into the haemocoel. Inoculation bypasses 158 
the midgut resulting in near 100% infection rates, circumventing problematic feeding rates 159 
[42]. It can be performed directly with quantified virus whereas titres in blood meals must 160 
be re-quantified after feeding and do not account for the differences in volume ingested. 161 
Intrathoracic inoculation is often the method of choice for studying VT owing to its high 162 
infection rate and dose uniformity. Bypassing the midgut infection and escape barriers 163 
allows direct calculation of the impact of the barriers present within the ovaries. However 164 
this method does not represent the natural mechanism of infection, and the incurred stress 165 
can indirectly affect results. 166 
There are no standardised vector competency methods, making comparisons 167 
difficult. Variations include inoculation route and dose, engorgement status, sample size, 168 
  
and colonised versus field-caught mosquitoes. These have been counteracted for HT by 169 
applying a corrective algorithm, predicting the ranking of American mosquitoes to 170 
disseminate and transmit RVFV starting from a theoretical uniformity [44]. However, data 171 
are insufficient to perform these corrective measures for the VT of RVFV. A comprehensive 172 
list of field and laboratory studies of VT of RVFV are summarised in Table 2. The data are 173 
limited, due in part to the requirement for colonised or semi-colonised mosquitoes with the 174 
ability to lay eggs, and the reliance on both mating and blood feeding with the latter 175 
performed at Biosafety Level (BSL) 3. Challenges encountered in rearing Aedes spp. in the 176 
laboratory, such as low hatching and survival rates have contributed to failures to detect 177 
TOT [92]. Reviews of successful studies of VT with other arboviruses have exposed further 178 
reasons for the limited data supporting this route for RVFV, as discussed below. 179 
Detection methods 180 
Virus detection assays for field and laboratory data are commonly performed on 181 
pooled larvae to facilitate the processing of large numbers. A linear inhibitory effect on 182 
detection has been reported; as the larvae pool size increases, detection by cell culture 183 
decreases, with a failure to detect Hart Park virus (HPV; unassigned Rhabdoviridae), or 184 
Turlock virus (TURV; Orthobunyvirus), in pools of more than 25 [93]. This is supported by 185 
studies of RVFV although no significant decrease in detection has been observed from adult 186 
pools  [94]. Therefore the use of pooled larvae in previous studies may have limited the 187 
potential to detect virus and caused the negative results [42,73,95]. If the testing of pooled 188 
larvae is considered necessary, a combination of assays can be used. ELISAs and inoculation 189 
into hamsters are both less susceptible to inhibition than plaque assay but are also less 190 
sensitive. PCR is both rapid and sensitive but extraction methods should be evaluated to 191 
limit the presence of inhibitory substances in RNA extracts from mosquito samples [96,97]. 192 
  
These methods can be streamlined to a high-throughput format to allow the processing of 193 
large numbers of individual mosquitoes. Testing in pools additionally increases the risk of 194 
sampling errors resulting from misidentification of a single mosquito or the introduction of 195 
contamination during pooling, sampling or handling the mosquitoes; a single positive leg is 196 
sufficient to cause a false positive [98]. The inclusion of engorged mosquitoes can also cause 197 
false positives as virus can be present in the blood meal of a refractory mosquito [99]. 198 
Therefore susceptibility or VT should be based on repeat isolation as performed in Kenya in 199 
1985, detecting RVFV in 19 pools across three years [64].  200 
Ovarian cycle 201 
The time taken by a microorganism to complete its development within a vector is 202 
termed the extrinsic incubation period. It is determined by the time required for virus to 203 
infect host cells, replicate, and disseminate, with delays associated with host barriers. 204 
Delays in the venereal transmission of dengue virus (DENV; Flavivirus), are shorter than 205 
those observed for TOT [82]. DENV was not detected in eggs until 73 hours post-mating. 206 
Though not proven, it is postulated that this delay is caused by the requirement for virus 207 
replication in the genital tract prior to virus entry into the egg, rather than the occurrence of 208 
direct transovum transmission. Virus is commonly observed in the ovaries, oviducts, and 209 
subsequently the oocytes at later time points than in other organs in orally infected 210 
mosquitoes [68,100], supporting the presence of an ovarian infection or escape barrier. 211 
The ovarian cycle utilised for detecting virus is therefore a decisive component for VT 212 
detection, for example autogenous mosquitoes can complete their first ovarian cycle 213 
without a blood meal. Virus dissemination to the ovaries in the haemolymph [101] will 214 
inevitably incur some delays, like the salivary glands, virus access is subject to any preceding 215 
barriers in the midgut. However, logistical complexities in harvesting eggs and offspring 216 
  
from multiple ovarian cycles at BSL 3 further limit studies. TOT of La Crosse virus (LACV,  217 
Orthobunyavirus) was detected in larvae from the second and third ovarian cycles but was 218 
absent in the first [102]. This delay was observed in both the orally and intrathoracically 219 
inoculated mosquitoes, despite the latter method circumventing the midgut, suggesting that 220 
the delay may be linked to the entry to or exit from reproductive tissue. LACV was detected 221 
seven days post-infection in the ovaries by which point the first eggs had already been 222 
oviposited or were refractory, and LACV was presumed to be unable to penetrate the 223 
chorionated egg. Yolk formation in the developing oocytes, termed vitellogenesis, is 224 
initiated immediately after ingestion of a blood meal so orally ingested virus must replicate 225 
rapidly to be transmitted within the same ovarian cycle.  The expansion of the ovaries 226 
during oogenesis may also increase the permeability of tissue to virus contributing to 227 
increased VT in subsequent cycles [103]. Absence of virus in the first gonotrophic cycle has 228 
been observed for chikungunya virus (CHIKV; Alphavirus),  [103] and YFV [104]. This 229 
contrasts with the detection of LACV and CEV in the progeny of Aedes spp. in the first to 230 
fourth ovarian cycles [105,106]; indicating VT efficiency is affected by the specificity of the 231 
vector-virus pairing.  232 
A delay in RVFV entry to the ovaries is not proven but may have contributed to the 233 
failures to detect RVFV in the first egg cycles in seven South African mosquito species [95]. 234 
Microscopy is needed to determine the mechanisms associated with RVFV entry or the 235 
barriers to the ovaries. RVFV antigen in the tissues and eggs of four intrathoracically 236 
infected Ae. mcintoshi  was visualised by immunocytochemistry; despite the small sample 237 
size, the findings offer significant support for TOT [84]. The high titres of virus observed 238 
within the oocytes infer prior replication in the ovaries. A system of tubular channels called 239 
the tracheae (composed of tracheal cells transporting oxygen to tissues) are proposed as a 240 
  
route for escape from the midgut [79]. RVFV tissue tropism suggests that virus could enter 241 
the ovaries via the tracheae or more directly via the ovarian sheath [84].  Evidence of LACV 242 
within the ovaries prior to dissemination from the midgut supports the hypothesis of direct 243 
transmission via the tracheal cells but if this is the case then testing legs as a method of 244 
dissemination would be unreliable [107]. Thus it is still necessary to investigate whether 245 
virus is modulated by a threshold, a physical barrier, a time dependant measure or via host 246 
control in these tissues.  247 
Crucially a female mosquito must survive for a time longer than the extrinsic 248 
incubation period in order to transmit virus to her offspring. This may require the 249 
completion of a second gonotrophic cycle.  Laboratory detection therefore requires large 250 
starting numbers to ensure adequate survival to these late time points.  Reduced survival 251 
and fecundity of RVFV infected Cx. pipiens has been observed [108,109] but there was no 252 
negative impact on survival when eggs were infected with CEV [61]. These factors are not 253 
only important with regard to detection but should also be accounted for in predictive 254 
models of VT. 255 
Time of sampling 256 
Assuming virus is passed to the egg, it must then pass transstadially from egg to 257 
larvae, to pupae, and to adult, disseminating to the salivary glands or ovaries for onward HT 258 
or VT. Hardy et al. [110] proposed that virus is inactivated during metamorphosis, which was 259 
supported by a reduction in viral titres transstadially during development [111]. In contrast, 260 
LACV transmission to progeny of orally infected Ae. triseriatus indicated that viral load was 261 
higher in larvae compared to eggs [106] and similarly increased in each stage from egg to 262 
adult with most larval and adult tissues supporting replication [112]. The increase of titres 263 
  
through development stages is likely associated with increased progeny size [106,112] and is 264 
worth considering to maximise the potential for detecting transovarially transmitted virus.  265 
G x G interactions 266 
Vector competence relies on the specific interaction between the vector and arbovirus 267 
genotypes, termed GxG (genotype-by-genotype) interactions [113]. Traits such as 268 
dissemination, midgut escape barrier and mortality are governed by adaptation by the virus 269 
to the vector and vice-versa [114–116]. These interactions are also critical for VT as 270 
demonstrated by the variable rates of TOT of three strains of St Louis encephalitis virus 271 
(SLEV; Flavivirus) in five mosquito species [117]. Studies of TOT of RVFV are often performed 272 
as a secondary activity to HT, producing basic observational data in support or opposition to 273 
its occurrence [73,95]. Those studies that assess a single virus strain and mosquito species 274 
are therefore limited in their potential to detect VT. 275 
Temperature 276 
The GxG principle was extended to integrate the interplay of environmental factors  277 
resulting in GxGxE (genotype-by-genotype-by-environment) [118,119]. Temperature is one 278 
of the best studied factors affecting HT competency. As temperature increases, typically 279 
increasing the rate of viral replication, the extrinsic incubation period decreases with low 280 
temperatures limiting transmission. There are, however, marked intra-species differences 281 
[120] and in some cases the inverse-relationship is observed with reduced survival and 282 
enhanced midgut escape and salivary gland infection barriers at higher temperatures [121]. 283 
Lower rearing temperatures can impact vector survival and susceptibility to virus [122,123] 284 
directly effecting downstream VT potential. Lower rearing temperatures increased the rate 285 
of vertical and transstadial transmission of SLEV [117,124] and WNV [125]. This may be 286 
linked to the increase in size and development time of the progeny allowing increased viral 287 
  
titres, and time for dissemination to the ovaries. Therefore, negative results for RVFV from 288 
eggs hatched and reared at 26oC may have been limited by the temperature [42,73],  (Table 289 
2). The species specific impact of temperature on fecundity and duration of gonotrophic 290 
cycles will further impact VT, highlighting the need to test a range of temperatures 291 
representative of diurnal range within the mosquito’s natural habitat. 292 
The ability of virus to survive long periods of time in eggs would have a significant 293 
impact on the potential globalisation of RVFV; allowing maintenance of virus in temperate 294 
regions where, for half of the year, conditions are too cold to support mosquito populations. 295 
In North America, there is evidence of WNV maintenance in infected diapausing female 296 
Culex spp. [126]. However in general, overwintering Culex are nulliparous (have not laid 297 
eggs) therefore do not seek a blood meal prior to hibernation [127].  Thus, for these 298 
mosquitoes to become infected with WNV they require infection by VT, not oral infection, 299 
prior to overwintering. VT of WNV by Culex mosquitoes and subsequent detection in 300 
overwintering populations has been recorded [111,128]. Therefore, when considering RVFV 301 
in temperate regions outside Africa, it may be necessary to consider a similar overwintering 302 
model. Culex mosquitoes tested for VT of RVFV are listed in Table 2, yet there is limited 303 
evaluation on the ability of mosquitoes from temperate regions to vertically transmit RVFV. 304 
Culex mosquitoes from the temperate Natal region of South Africa yielded negative results 305 
for VT [95]. Future studies should be performed to evaluate VT of RVFV in European and 306 
American mosquito populations. 307 
5. CONCLUSION 308 
Despite widespread citation in the literature, current data are insufficient to prove 309 
VT of RVFV at present. Whilst reports from Kenya in 1985 infer the likelihood of VT, 310 
supporting data in the three decades since is limited to the detection of RVFV in the oocytes 311 
  
of four mosquitoes by immunocytochemistry. Factors limiting the detection of transovarian 312 
transmission have been identified, highlighting the need for improved colonisation 313 
techniques to enable the study of a range of: vector-virus pairs, temperatures, ovarian and 314 
life cycle stages, and parent and progeny. The theoretical ability of virus to survive until local 315 
conditions are favourable to support HT is extremely relevant for virus establishment under 316 
new climatic conditions in areas currently free from RVFV. Climate prediction suggest  317 
Northern Europe will become warmer and wetter, thereby increasing mosquito numbers 318 
[129], and contributing to a rise in the predicted risk of arbovirus establishment [130]. Thus 319 
it is increasingly important to study the ability of these mosquitoes to maintain and transmit 320 
RVFV.  321 
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Table 1. Mosquito species demonstrating transmission of Rift Valley fever virus in the 
laboratory 
Genus Species 
Mosquito 
origin 
Strains 
Blood titre 
(log10PFU/ 
mL) 
Ingested titre 
(Log10PFU/ 
mosquito) 
Reference 
 aegypti 
S. Africa, 
Kenya 
AN1830, ZH501, 
Zinga, K21445 
*>8 3.3-7.5 [42,95] 
Aedes 
albopictus USA ZH501  4.3-5.9 [131] 
argenteopunctatus S. Africa AN1830 7.8-9.8  [132] 
atlanticus USA ZH501 8.3 -9.5  [133] 
caballus S Africa    [134] 
canadensis USA ZH501  6.2-7.2 [135] 
cantator USA ZH501  6.2-7.2 [135] 
caspius Egypt ZH501,  Egypt93 *5.3-11.1 *2.8-8.6 [136,137] 
circumluteolus 
S. Africa, 
Kenya 
AN1830, ZH501, 
Zinga, K-21445 
6-10.2 
 
3.3-7.5 [42,138] 
dentatus S. Africa AN1830 *  [95] 
excrucians USA ZH501  6.2-7.2 [135] 
fowleri Senegal ZH501, Zinga  1.3-7.2 [73,139] 
japonicas japonicus USA ZH501 4.3->8.5  [140] 
juppi S. Africa AN1830 *  [95] 
lineatopennis S. Africa AN1830 *  [95] 
mcintoshi Kenya 
ZH501, Zinga, 
K-21445 
>8 3.3-7.5 [42] 
notoscriptus Australia ZH501 7  [141] 
palpalis CAR 
ZH501, Zinga, 
K21445 
>8 3.3-7.5 [42] 
sollicitans USA ZH501  6.2-7.2 [135] 
stricticus Canada ZH501 7.9-9.4  [142] 
taeniorhynchus USA ZH501 7.9 4.7-7.2 
[120,135,14
3] 
unidentatus S. Africa AN1830 6.8-7.8  [132] 
vexans 
USA, 
Senegal 
ZH501, 
Mauritania 
6.7-10.2  
 
 
[133,144–
146] 
vigilax Australia ZH501 7 
 
[141] 
Anopheles 
multicolor Egypt ZH501 * * [137] 
pharoensis Egypt ZH501 * * [137] 
Coquillettidia perturbans Canada, USA ZH501 6.6-9.5  [133,142] 
Culex 
annulirostris Australia ZH501 7  [141] 
antennatus Egypt, Kenya 
ZH501, Egypt93, 
Zinga, K21445 
*5.3-11.1 *2.8-8.6  [42,136,137] 
erythrothorax USA ZH501 >8.8  [145] 
neavei S. Africa 
 
*  [147] 
nigripalpus USA ZH501 5.7- >8.8  [133,145] 
perexiguus Egypt ZH501, Egypt93 5.3-11.1 2.8-8.6 [136] 
pipiens molestus USA ZH501 7.5- >9 
 
[148] 
pipiens 
USA, Egypt, 
Algeria, 
Morroco, 
Tunisia 
ZH501, Clone13, 
Zinga, K21445 
*5.3-11.1 2.4-8.6 
[42,47,49,70
,99,120,136,
142,145,148
] 
poicilipes 
Senegal,  
S. Africa 
AN1830, 
Mauritania 
*6.4-8.9 
  
[132,146] 
  
quinquefasciatus 
Senegal,  
S. Africa, 
Australia, 
Kenya 
AN1830, ZH501, 
Mauritania 
 
*6.2-10.3 
 
[95,141,146,
149] 
salinarius USA ZH501 
 
6.2-7.2  [135] 
tarsalis USA, Canada ZH501 7.3 -9.4  6.2-7.2 
[135,142,14
5] 
theileri S. Africa AN1830 *  [95,147] 
tritaeniorhynchus S. Africa AN1830 Ϯ 6.9-7.9  [150] 
univittatus S. Africa AN1830 *  [95] 
zombaensis 
Zimbabwe  
S. Africa, 
Kenya 
AN1830, ZH501 *8.0-9.9 4.1-7.8 
[138,147,14
9] 
erraticus USA ZH501 7.3-10.2   [144,145] 
territans USA ZH501 
 
6.2-7.2 [135] 
Eretmapodites 
chrysogaster Uganda 
  
 [151] 
quinquevittatus S. Africa AN1830 *  [95,147] 
Psorophora ferox USA ZH501 8.3  [133] 
We employed the classification system of Wilkerson et al. [152] for Aedini species. 
Subgeneric placement of species might be found in Harbach, 2008 [153]. Data was updated 
from [41,44], additional studies were identified in NCBI PubMed using the search terms;  
Rift Valley fever AND competence OR saliva OR transmission. A range of viral doses are used 
to orally infect mosquitoes in the laboratory, historically these were quantified by 
calculating the lethal dose in mammalian models. The impact of species, breed, age and 
individual used for calculations makes comparison difficult, therefore these data have been 
omitted*. Ϯ Focussed forming units.  TCID50 results have been standardised to PFU by 
multiplying by 0.69.  
  
Table 2: Studies of transovarian transmission of Rift Valley fever virus in arthropods. 
Genus Species 
Study 
(inoculation) 
Locality TOT 
Life Cycle stage n = 
(all life 
stages) 
Temperature: 
Larvae/Adult 
Ovarian 
cycle 
Pool 
size 
Detection 
assay 
Reference Adult 
male 
Progeny 
Egg Larvae Pupae Adult 
Aedes 
aegypti 
Lab (O-AM) S. Africa x -   -  2,811 26oC 1 100 AM [95] 
Lab (IT) Kenya x - -    759 26oC 1-3 25 PA [42] 
Field Kenya x  -  - - 745 n/a - ~50 AM [64] 
caballus Lab S. Africa x -   -  174 26oC 1 100 AM [95] 
calceatus Field Kenya x - -    89 n/a - ~50 AM [64] 
circumluteolus Lab (IT) Kenya x - -    157 26oC 1-3 25 PA [42] 
cumminsii Field Kenya x  -    1,651 n/a - ~50 AM [64] 
deboeri Field Kenya x  - - -  8 n/a - <5 AM [64] 
dentatus Field Kenya x  - - - - 37 n/a - 37 AM [64] 
fowleri Lab (IT) Senegal x - -    721 26oC 1-3 <10 AM, PA [73] 
fulgens Field Kenya x - -  - - 391 n/a - ~50 AM [64] 
juppi 
Lab S. Africa x -   -  81 26oC 1 100 AM [95] 
Lab (IT) S. Africa x  - - -  - - - 1 AM, MIC  [132] 
Field S. Africa x  - - -  5,425 26oC - 100 PA, AM [92] 
mcintoshi* 
Lab (IT) Kenya x - -    942 26oC 1-3 25 PA [42] 
Lab S. Africa x -   -  401 26oC 1 100 AM [95] 
Field Kenya   - - -  31,844 n/a - ~50 AM [64] 
Lab (IT) Kenya  -  - - - 4 26oC 1 1 ICC [84] 
natalensis Field Kenya x - -  - - 50 n/a - ~50 AM [64] 
quasiunivittatus Field Kenya x  -  - - 747 n/a - ~50 AM [64] 
sudanensis Field Kenya x  -   - 35 n/a - ~50 AM [64] 
vexans Field Sudan  - - - -  398 n/a n/a  PCR [90] 
vittatus Field Kenya x - -  - - 1,242 n/a - ~50 AM [64] 
Culex 
annulirostris Field Kenya x  - - -  16 n/a - <16 AM [64] 
antennatus Field Kenya x  -    112 n/a - <50 AM [64] 
hopkinsi Field Kenya x - -  - - 410 n/a - ~50 AM [64] 
  
pipiens Field Kenya x - -   - 114 n/a - <50 AM [64] 
quinquefasciatus Field   - - - -  1,200 n/a n/a  PCR [90] 
theileri Lab S. Africa x -   -  822 26oC 1 100 AM [95] 
univittatus 
Field Kenya x  - - - - 44 n/a - 44 AM [64] 
Lab S. Africa x -   -  >218 26oC 1 100 AM [95] 
vansomereni Field Kenya x - -  - - 1,048 n/a - ~50 AM [64] 
zombaensis Field Kenya x  -  -  191 n/a - ~50 AM [64] 
Eretmapodites 
chrysogaster Field Kenya x - -  - - 25 n/a - 25 AM [64] 
quinquevittatus 
Field Kenya x - -  - - 2,659 n/a - ~50 AM [64] 
Lab (IT) S. Africa x - -    1,280 26oC 1-3 25 PA [42] 
Lab S. Africa x -   -  1,285 26oC 1 100 AM [95] 
silvestris Field Kenya x - -    1,957 n/a - ~50 AM [64] 
subsimplicipes Field Kenya x - - - -  27 n/a - 27 AM [64] 
Hyalomma truncatum Lab (IC) S. Africa x -   - - - 26oC 1 1 PA [40] 
*Originally identified as Ae. lineatopennis  [89]. We employed the classification system of Wilkerson et al. [152] for Aedini species. Subgeneric 
placement of species might be found in Harbach, 2008 [153]. IT: intrathoracic inoculation, IC: intracoelomic inoculation, O-AM: orally infected 
animal model, O-B: orally infected blood meal, TOT: transovarian transmission, ICC: immunocytochemistry, -: not tested or data not supplied, 
x: negative, MIC: mouse intracerebral inoculation, PA: plaque assay, PCR: polymerase chain reaction. 
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Figure 1. Transmission cycle Rift Valley fever virus. 
Arrows represent transmission direction. Solid lines represent established routes supported 
by experimental data and dotted lines suspected routes but current data is insufficient to 
verify (Modified from: Chevalier et al., 2010). 
 
Figure 2: Schematic of the arbovirus migratory route through its mosquito vector.  
Blue circles represent virus; anatomical barriers that virus must transition are numbered; 1. 
Midgut infection barrier; 2. Midgut escape barrier; 3. Salivary gland infection barrier; 4. 
Salivary gland escape barrier, 5. Ovarian tissue barriers. 
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